Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion description "[Thus, the use of synthetic inhibitors of miR-221 may prove to be a promising approach to liver cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion evidence source_evidence_literature NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion SIO_000772 20018759 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion wasDerivedFrom befree-2016 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion wasGeneratedBy ECO_0000203 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- befree-2016 importedOn "2016-02-19" NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.